遇见数据集

Supplementary Material for: Ferritin to Transferrin Ratio: a new prognostic factor for renal cell carcinoma

收藏
DataCite Commons2025-01-26 更新2025-05-07 收录
官方服务:

资源简介:

Objectives: To assess the prognostic value of the preoperative serum ferritin-to-transferrin ratio (FTR) in renal cell carcinoma (RCC). Methods:We retrospectively reviewed data from 226 patients who underwent surgery for non-metastatic RCC at our institution between January 1, 2012, and June 30, 2021. Time-dependent receiver operating characteristic (timeROC) analysis identified the optimal FTR cut-off, dividing patients into high and low FTR groups. Propensity score matching (PSM) adjusted for baseline differences. Recurrence-free survival (RFS) and overall survival (OS) were analyzed using the Kaplan–Meier method and Cox regression, with a nomogram validating the results. Results: The timeROC analysis showed a 5-year area under the curve (AUC) of 0.786 for FTR, with 68.4% sensitivity and 86.7% specificity at a cut-off of 177.1. High FTR and clinical stage were independent risk factors for OS and RFS. The hazard ratios (HR) for OS and RFS in the high and low FTR groups were 2.598(1.087-6.213), P=0.032 and 2.591(1.105-6.074), P=0.029, respectively. Kaplan–Meier curves showed significant differences post-PSM (log rank P<0.05). The nomogram validation indicated high predictive accuracy with a C-index of 0.867 (95% CI: 0.836-0.899) for OS and 0.808 (95% CI: 0.764-0.852) for RFS. Conclusion:Our findings suggest that FTR may serve as an independent prognostic risk factor in patients with locally and locally advanced renal cell carcinoma.

研究目的:评估术前血清铁蛋白转铁蛋白比值(ferritin-to-transferrin ratio, FTR)对肾细胞癌(renal cell carcinoma, RCC)的预后价值。研究方法:本研究回顾性分析了2012年1月1日至2021年6月30日期间,于本机构接受非转移性肾细胞癌手术治疗的226例患者的临床资料。采用时间依赖性受试者工作特征(time-dependent receiver operating characteristic, timeROC)分析确定FTR的最佳截断值,将患者划分为高FTR组与低FTR组。通过倾向性评分匹配(propensity score matching, PSM)校正基线差异。采用Kaplan-Meier法与Cox回归分析无复发生存期(recurrence-free survival, RFS)与总生存期(overall survival, OS),并通过列线图(nomogram)验证研究结果。研究结果:时间ROC分析显示,FTR的5年曲线下面积(area under the curve, AUC)为0.786,当截断值取177.1时,其灵敏度为68.4%,特异度为86.7%。高FTR水平与临床分期均为总生存期与无复发生存期的独立危险因素。高、低FTR组的总生存期与无复发生存期的风险比(hazard ratios, HR)分别为2.598(95%CI:1.087~6.213),P=0.032,以及2.591(95%CI:1.105~6.074),P=0.029。Kaplan-Meier曲线显示,倾向性评分匹配后两组间存在显著差异(log-rank检验P<0.05)。列线图验证结果显示其预测准确性较高,总生存期的C指数(C-index)为0.867(95%CI:0.836~0.899),无复发生存期的C指数为0.808(95%CI:0.764~0.852)。研究结论:本研究结果表明,FTR可作为局部及局部进展性肾细胞癌患者的独立预后危险因素。

提供机构:
Karger Publishers
创建时间:
2025-01-20
二维码
社区交流群
二维码
科研交流群
商业服务